{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T19:12:37Z","timestamp":1783537957769,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cancer patients face a high risk of thromboembolic complications due to disease-, treatment-, and patient-related factors. Chemotherapy regimens such as anthracyclines and alkylating agents can increase both venous and arterial thrombosis, leading to significant morbidity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case summary<\/jats:title>\n                    <jats:p>A 44-year-old woman with invasive ductal carcinoma of the right breast underwent right mastectomy and received adjuvant chemotherapy with doxorubicin (60\u00a0mg\/m\u00b2) and cyclophosphamide (600\u00a0mg\/m\u00b2). Five days after her second treatment cycle, she presented with chest pain. Electrocardiography showed inferolateral ST-segment elevation, and echocardiography revealed a left ventricular ejection fraction (LVEF) of 38%. Coronary angiography demonstrated total occlusion of the distal left anterior descending and circumflex arteries. She was treated with dual antiplatelet therapy, low-molecular-weight heparin, and a glycoprotein IIb\/IIIa inhibitor. Follow-up angiography on day five showed complete thrombus resolution and restoration of TIMI III flow. During long-term follow-up, her left ventricular function recovered (LVEF 50%) and her cancer remained in complete remission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case illustrates a rare but clinically important complication of adjuvant doxorubicin\u2013cyclophosphamide therapy, presenting as subacute inferolateral myocardial infarction secondary to coronary thrombosis. Awareness of this potential adverse effect and early management are crucial for improved outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-026-05512-6","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T10:55:15Z","timestamp":1767956115000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Chemotherapy-associated coronary thrombosis presenting as acute coronary syndrome in breast cancer: a case report"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3521-7133","authenticated-orcid":false,"given":"Oya","family":"Imadoglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7271-6858","authenticated-orcid":false,"given":"Emre Emrah","family":"Demirci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4628-6672","authenticated-orcid":false,"given":"Sefa","family":"Sural","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"issue":"2","key":"5512_CR1","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jaccao.2021.03.001","volume":"3","author":"L Gervaso","year":"2021","unstructured":"Gervaso L, Dave H, Khorana AA. Venous and arterial thromboembolism in patients with cancer: JACC: cardiooncology State-of-the-Art review. JACC CardioOncol. 2021;3(2):173\u201390. https:\/\/doi.org\/10.1016\/j.jaccao.2021.03.001. Published 2021 Apr 20.","journal-title":"JACC CardioOncol"},{"issue":"29","key":"5512_CR2","doi-asserted-by":"publisher","first-page":"4839","DOI":"10.1200\/JCO.2009.22.3271","volume":"27","author":"AA Khorana","year":"2009","unstructured":"Khorana AA, Connolly GC. Assessing risk of venous thromboembolism in the patient with cancer. J Clin Oncol. 2009;27(29):4839\u201347. https:\/\/doi.org\/10.1200\/JCO.2009.22.3271.","journal-title":"J Clin Oncol"},{"key":"5512_CR3","doi-asserted-by":"publisher","first-page":"694711","DOI":"10.3389\/fcvm.2021.694711","volume":"8","author":"PY Hsu","year":"2021","unstructured":"Hsu PY, Mammadova A, Benkirane-Jessel N, et al. Updates on anticancer Therapy-Mediated vascular toxicity and new horizons in therapeutic strategies. Front Cardiovasc Med. 2021;8:694711. https:\/\/doi.org\/10.3389\/fcvm.2021.694711. Published 2021 Jul 27.","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"5512_CR4","doi-asserted-by":"publisher","first-page":"102393","DOI":"10.1016\/j.rpth.2024.102393","volume":"8","author":"MA Cheong","year":"2024","unstructured":"Cheong MA, Leader A. Cancer and arterial thrombosis: therapeutic options. Res Pract Thromb Haemost. 2024;8(3):102393. https:\/\/doi.org\/10.1016\/j.rpth.2024.102393. Published 2024 Mar 27.","journal-title":"Res Pract Thromb Haemost"},{"issue":"4","key":"5512_CR5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2165\/00002018-200022040-00002","volume":"22","author":"VB Pai","year":"2000","unstructured":"Pai VB, Nahata MC. Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention. Drug Saf. 2000;22(4):263\u2013302. https:\/\/doi.org\/10.2165\/00002018-200022040-00002.","journal-title":"Drug Saf"},{"key":"5512_CR6","doi-asserted-by":"publisher","first-page":"847012","DOI":"10.3389\/fcvm.2022.847012","volume":"9","author":"MB Morelli","year":"2022","unstructured":"Morelli MB, Bongiovanni C, Da Pra S, et al. Cardiotoxicity of anticancer drugs: molecular mechanisms and strategies for cardioprotection. Front Cardiovasc Med. 2022;9:847012. https:\/\/doi.org\/10.3389\/fcvm.2022.847012. Published 2022 Apr 15.","journal-title":"Front Cardiovasc Med"},{"key":"5512_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3389\/fcvm.2020.00026","volume":"7","author":"D Cardinale","year":"2020","unstructured":"Cardinale D, Iacopo F, Cipolla CM. Cardiotoxicity of anthracyclines. Front Cardiovasc Med. 2020;7:26. https:\/\/doi.org\/10.3389\/fcvm.2020.00026. Published 2020 Mar 18.","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"5512_CR8","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.cardfail.2016.04.008","volume":"22","author":"V Mercurio","year":"2016","unstructured":"Mercurio V, Pirozzi F, Lazzarini E, et al. Models of heart failure based on the cardiotoxicity of anticancer drugs. J Card Fail. 2016;22(6):449\u201358. https:\/\/doi.org\/10.1016\/j.cardfail.2016.04.008.","journal-title":"J Card Fail"},{"issue":"36","key":"5512_CR9","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","volume":"45","author":"C Vrints","year":"2024","unstructured":"Vrints C, Andreotti F, Koskinas KC, et al. 2024 ESC guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024;45(36):3415\u2013537. https:\/\/doi.org\/10.1093\/eurheartj\/ehae177.","journal-title":"Eur Heart J"},{"issue":"2","key":"5512_CR10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jaccao.2021.02.007","volume":"3","author":"FI Mulder","year":"2021","unstructured":"Mulder FI, Horv\u00e1th-Puh\u00f3 E, van Es N, et al. Arterial thromboembolism in cancer patients: A Danish Population-Based cohort study. JACC CardioOncol. 2021;3(2):205\u201318. https:\/\/doi.org\/10.1016\/j.jaccao.2021.02.007. Published 2021 Apr 20.","journal-title":"JACC CardioOncol"},{"issue":"8","key":"5512_CR11","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.jacc.2017.06.047","volume":"70","author":"BB Navi","year":"2017","unstructured":"Navi BB, Reiner AS, Kamel H, et al. Risk of arterial thromboembolism in patients with cancer. J Am Coll Cardiol. 2017;70(8):926\u201338. https:\/\/doi.org\/10.1016\/j.jacc.2017.06.047.","journal-title":"J Am Coll Cardiol"},{"key":"5512_CR12","unstructured":"Kushner A, West WP, Khan SMZ et al. Virchow Triad. [Updated 2024 Jun 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK539697\/."},{"issue":"5","key":"5512_CR13","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.12.005","volume":"27","author":"S Takeshita","year":"2018","unstructured":"Takeshita S, Ogata T, Mera H, et al. Multiple thrombi in the heart in Trousseau syndrome caused by pancreatic carcinoma. J Stroke Cerebrovasc Dis. 2018;27(5):e75\u20137. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2017.12.005.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"5","key":"5512_CR14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11936-018-0635-x","volume":"20","author":"M Tuzovic","year":"2018","unstructured":"Tuzovic M, Herrmann J, Iliescu C, et al. Arterial thrombosis in patients with cancer. Curr Treat Options Cardiovasc Med. 2018;20(5):40. https:\/\/doi.org\/10.1007\/s11936-018-0635-x. Published 2018 Apr 7.","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"5","key":"5512_CR15","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.ejim.2013.01.017","volume":"24","author":"HA Goubran","year":"2013","unstructured":"Goubran HA, Burnouf T, Radosevic M, et al. The platelet-cancer loop. Eur J Intern Med. 2013;24(5):393\u2013400. https:\/\/doi.org\/10.1016\/j.ejim.2013.01.017.","journal-title":"Eur J Intern Med"},{"issue":"3","key":"5512_CR16","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1055\/s-0034-1370767","volume":"40","author":"HA Goubran","year":"2014","unstructured":"Goubran HA, Stakiw J, Radosevic M, et al. Platelet-cancer interactions. Semin Thromb Hemost. 2014;40(3):296\u2013305. https:\/\/doi.org\/10.1055\/s-0034-1370767.","journal-title":"Semin Thromb Hemost"},{"issue":"6","key":"5512_CR17","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/sj.neo.7900263","volume":"4","author":"GJ Caine","year":"2002","unstructured":"Caine GJ, Stonelake PS, Lip GYH, Kehoe ST. The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia. 2002;4(6):465\u201373. https:\/\/doi.org\/10.1038\/sj.neo.7900263.","journal-title":"Neoplasia"},{"issue":"1","key":"5512_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1136\/jcp.2005.035105","volume":"60","author":"R Bussani","year":"2007","unstructured":"Bussani R, De-Giorgio F, Abbate A, Silvestri F. Cardiac metastases. J Clin Pathol. 2007;60(1):27\u201334. https:\/\/doi.org\/10.1136\/jcp.2005.035105.","journal-title":"J Clin Pathol"},{"issue":"4","key":"5512_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jccase.2015.11.002","volume":"13","author":"N Chiba","year":"2015","unstructured":"Chiba N, Matsuzaki M, Furuya S, et al. Complete occlusion of the left main trunk coronary artery by a cardiac papillary fibroelastoma in a hemodynamically unstable patient. J Cardiol Cases. 2015;13(4):97\u2013100. https:\/\/doi.org\/10.1016\/j.jccase.2015.11.002. Published 2015 Dec 29.","journal-title":"J Cardiol Cases"},{"key":"5512_CR20","doi-asserted-by":"publisher","first-page":"110","DOI":"10.2174\/1874192401408010110","volume":"8","author":"YH Juan","year":"2014","unstructured":"Juan YH, Chatzizisis YS, Saboo SS, Rocha T, Steigner ML. Tumor encasement of the right coronary artery: role of anatomic and functional imaging in diagnosis and therapeutic management. Open Cardiovasc Med J. 2014;8:110\u20132. https:\/\/doi.org\/10.2174\/1874192401408010110. Published 2014 Nov 13.","journal-title":"Open Cardiovasc Med J"},{"issue":"13","key":"5512_CR21","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1161\/CIRCULATIONAHA.115.018347","volume":"133","author":"J Herrmann","year":"2016","unstructured":"Herrmann J, Yang EH, Iliescu CA, et al. Vascular toxicities of cancer therapies: the old and the New \u2014 An evolving avenue. Circulation. 2016;133(13):1272\u201389. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.018347.","journal-title":"Circulation"},{"issue":"3","key":"5512_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11912-016-0502-4","volume":"18","author":"K Marmagkiolis","year":"2016","unstructured":"Marmagkiolis K, Finch W, Tsitlakidou D, et al. Radiation toxicity to the cardiovascular system. Curr Oncol Rep. 2016;18(3):15. https:\/\/doi.org\/10.1007\/s11912-016-0502-4.","journal-title":"Curr Oncol Rep"},{"issue":"7","key":"5512_CR23","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1056\/NEJM198802183180703","volume":"318","author":"MN Levine","year":"1988","unstructured":"Levine MN, Gent M, Hirsh J, et al. The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer. N Engl J Med. 1988;318(7):404\u20137. https:\/\/doi.org\/10.1056\/NEJM198802183180703.","journal-title":"N Engl J Med"},{"issue":"2","key":"5512_CR24","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1200\/JCO.1991.9.2.286","volume":"9","author":"T Saphner","year":"1991","unstructured":"Saphner T, Tormey DC, Gray R. Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer. J Clin Oncol. 1991;9(2):286\u201394. https:\/\/doi.org\/10.1200\/JCO.1991.9.2.286.","journal-title":"J Clin Oncol"},{"issue":"5","key":"5512_CR25","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/s0002-9343(89)80604-7","volume":"87","author":"JG Wall","year":"1989","unstructured":"Wall JG, Weiss RB, Norton L, et al. Arterial thrombosis associated with adjuvant chemotherapy for breast carcinoma: a cancer and leukemia group B study. Am J Med. 1989;87(5):501\u20134. https:\/\/doi.org\/10.1016\/s0002-9343(89)80604-7.","journal-title":"Am J Med"},{"key":"5512_CR26","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.3389\/fphar.2019.01531","volume":"10","author":"H He","year":"2020","unstructured":"He H, Wang L, Qiao Y, et al. Doxorubicin induces endotheliotoxicity and mitochondrial dysfunction via ROS\/eNOS\/NO pathway. Front Pharmacol. 2020;10:1531. https:\/\/doi.org\/10.3389\/fphar.2019.01531. Published 2020 Jan 10.","journal-title":"Front Pharmacol"},{"issue":"Suppl 35","key":"5512_CR27","doi-asserted-by":"publisher","first-page":"S4367","DOI":"10.21037\/jtd.2018.12.79","volume":"10","author":"O Oren","year":"2018","unstructured":"Oren O, Herrmann J. Arterial events in cancer patients\u2014the case of acute coronary events. J Thorac Dis. 2018;10(Suppl 35):S4367\u201385. https:\/\/doi.org\/10.21037\/jtd.2018.12.79.","journal-title":"J Thorac Dis"},{"issue":"24","key":"5512_CR28","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.jacc.2009.02.050","volume":"53","author":"ET Yeh","year":"2009","unstructured":"Yeh ET, Bickford CL. Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. J Am Coll Cardiol. 2009;53(24):2231\u201347. https:\/\/doi.org\/10.1016\/j.jacc.2009.02.050.","journal-title":"J Am Coll Cardiol"},{"key":"5512_CR29","doi-asserted-by":"publisher","unstructured":"Dhesi S, Chu MP, Blevins G et al. Cyclophosphamide-Induced Cardiomyopathy: A Case Report, Review, and Recommendations for Management. J Investig Med High Impact Case Rep. 2013;1(1):2324709613480346. Published 2013 Jan 1. https:\/\/doi.org\/10.1177\/2324709613480346.","DOI":"10.1177\/2324709613480346"},{"issue":"50","key":"5512_CR30","doi-asserted-by":"publisher","first-page":"e18249","DOI":"10.1097\/MD.0000000000018249","volume":"98","author":"LC Jang","year":"2019","unstructured":"Jang LC, Choi YJ. Acute arterial thrombosis during adjuvant Adriamycin-cyclophosphamide chemotherapy in a patient with early breast cancer: A case report. Med (Baltim). 2019;98(50):e18249. https:\/\/doi.org\/10.1097\/MD.0000000000018249.","journal-title":"Med (Baltim)"},{"issue":"41","key":"5512_CR31","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"AR Lyon","year":"2022","unstructured":"Lyon AR, L\u00f3pez-Fern\u00e1ndez T, Couch LS, et al. 2022 ESC guidelines on cardio-oncology developed in collaboration with the European hematology association (EHA), the European society for therapeutic radiology and oncology (ESTRO) and the international Cardio-Oncology society (IC-OS). Eur Heart J. 2022;43(41):4229\u2013361. https:\/\/doi.org\/10.1093\/eurheartj\/ehac244.","journal-title":"Eur Heart J"},{"issue":"15","key":"5512_CR32","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.2217\/fon-2017-0543","volume":"14","author":"M Zaleska","year":"2018","unstructured":"Zaleska M, Mozenska O, Bil J. Statins use and cancer: an update. Future Oncol. 2018;14(15):1497\u2013509. https:\/\/doi.org\/10.2217\/fon-2017-0543.","journal-title":"Future Oncol"},{"issue":"7","key":"5512_CR33","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/clc.22007","volume":"35","author":"SW Yusuf","year":"2012","unstructured":"Yusuf SW, Daraban N, Abbasi N, Lei X, Durand JB, Daher IN. Treatment and outcomes of acute coronary syndrome in the cancer population. Clin Cardiol. 2012;35(7):443\u201350. https:\/\/doi.org\/10.1002\/clc.22007.","journal-title":"Clin Cardiol"},{"issue":"2","key":"5512_CR34","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jaccao.2019.11.001","volume":"1","author":"Y Ueki","year":"2019","unstructured":"Ueki Y, V\u00f6geli B, Karagiannis A, et al. Ischemia and bleeding in cancer patients undergoing percutaneous coronary intervention. JACC CardioOncol. 2019;1(2):145\u201355. https:\/\/doi.org\/10.1016\/j.jaccao.2019.11.001. Published 2019 Dec 17.","journal-title":"JACC CardioOncol"},{"key":"5512_CR35","doi-asserted-by":"publisher","unstructured":"Guarnieri G, Mele D, Briguglia D, Simultaneous acute thrombosis of two coronary arteries leading to stemi and cardiogenic shock: a case report and review of literature., Eur Heart J Supplements, 27, Issue Supplement_5, May 2025, suaf076.450, https:\/\/doi.org\/10.1093\/eurheartjsupp\/suaf076.450.","DOI":"10.1093\/eurheartjsupp\/suaf076.450"},{"issue":"24","key":"5512_CR36","doi-asserted-by":"publisher","first-page":"7511","DOI":"10.3390\/jcm13247511","volume":"13","author":"G Guarnieri","year":"2024","unstructured":"Guarnieri G, Mele D, Briguglia D, et al. A STEMI complicated by cardiogenic shock due to simultaneous acute thrombosis of two coronary vessels in the \u2018Deadly double infarct syndrome\u2019: A case report and discussion of literature. J Clin Med. 2024;13(24):7511. https:\/\/doi.org\/10.3390\/jcm13247511. Published 2024 Dec 10.","journal-title":"J Clin Med"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-05512-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05512-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05512-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:31:14Z","timestamp":1781627474000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-05512-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5512"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-05512-6","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The preparation of this case report followed both institutional and national ethical standards, in accordance with the principles outlined in the Declaration of Helsinki. In line with local and national policies, ethical committee approval was not necessary for individual patient case reports. Written consent for the publication of all medical information and related images was obtained from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient provided written informed consent for the publication of all case details and associated images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"124"}}